Company profile for Harness Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Harness Therapeutics is a biotechnology company that focuses on developing a platform designed to facilitate the physiological upregulation of critical, validated neurodegenerative targets. The company's platform addresses unmet medical needs and creates differentiated products that are not achievable with other technologies. The core of Harness Therapeutics' platform is the ability to enhance translation, thereby enabling cli...
Harness Therapeutics is a biotechnology company that focuses on developing a platform designed to facilitate the physiological upregulation of critical, validated neurodegenerative targets. The company's platform addresses unmet medical needs and creates differentiated products that are not achievable with other technologies. The core of Harness Therapeutics' platform is the ability to enhance translation, thereby enabling clients to boost the expression of nearly any protein of choice. This approach holds promise for addressing neurodegenerative targets and advancing the development of innovative and differentiated therapeutic solutions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Minerva Building (B250), Babraham Research Campus, Cambridge, CB22 3AT, United...
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/06/3161403/0/en/Harness-Therapeutics-Announces-Launch-of-MISBA-Duo-Platform-and-Research-Collaboration-with-Ono-Venture-Investment.html

GLOBENEWSWIRE
06 Oct 2025

https://www.globenewswire.com/news-release/2025/01/27/3015281/0/en/Harness-Therapeutics-appoints-Dr-Heather-Preston-as-Chair-and-secures-new-funding-from-Ono-Venture-Investment-to-accelerate-delivery-of-transformational-neurodegeneration-pipeline.html

GLOBENEWSWIRE
27 Jan 2025

https://www.globenewswire.com/news-release/2024/09/04/2940231/0/en/Harness-Therapeutics-Appoints-Experienced-R-D-Executive-and-Physician-Scientist-Dr-Paulo-Fontoura-as-Non-Executive-Director.html

GLOBENEWSWIRE
04 Sep 2024

https://www.globenewswire.com/news-release/2024/05/30/2890588/0/en/Harness-Therapeutics-appoints-Leading-World-Experts-in-Neurodegenerative-Diseases-to-its-Scientific-Advisory-Board-SAB.html

GLOBENEWSWIRE
30 May 2024

https://www.globenewswire.com/news-release/2024/04/24/2868316/0/en/Harness-Therapeutics-Appoints-Seasoned-Biopharmaceutical-Leader-Ms-Meenu-Chhabra-Karson-as-Board-Chair.html

GLOBENEWSWIRE
24 Apr 2024

https://www.globenewswire.com//news-release/2023/11/28/2786691/0/en/Harness-Therapeutics-secures-additional-4-million-funding-to-pursue-physiological-upregulation-approach-to-treat-neurodegenerative-diseases.html

GLOBENEWSWIRE
28 Nov 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty